X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/taigen-successfully-completes-tg-1000-phase-iii-study-302120368.html
https://www.prnewswire.com/news-releases/taigen-enters-exclusive-license-agreement-with-ysp-301953054.html
https://www.prnewswire.com/news-releases/taigen-enters-exclusive-license-agreement-with-joincare-for-tg-1000-in-china-301778308.html
https://www.biospectrumasia.com/news/26/22140/taiwans-taigen-biotech-takes-pan-influenza-antiviral-drug-to-china.html
https://en.prnasia.com/releases/global/taigen-partners-with-gpcr-to-develop-burixafor-taigexyn-r--297914.shtml
https://www.prnewswire.com/news-releases/taigen-announces-fda-approval-of-ind-for-its-flu-antiviral-tg-1000-301164444.html
https://en.prnasia.com/releases/global/taigen-announces-fda-approval-of-ind-for-its-flu-antiviral-tg-1000-296876.shtml
Market Place
Share 
